NEWSMAX INC (NMAX) Stock Fundamental Analysis

NYSE:NMAX • US65250K1051

5.56 USD
-0.06 (-1.07%)
At close: Feb 23, 2026
5.61 USD
+0.05 (+0.9%)
Pre-Market: 2/24/2026, 7:17:49 AM
Fundamental Rating

2

Taking everything into account, NMAX scores 2 out of 10 in our fundamental rating. NMAX was compared to 91 industry peers in the Media industry. The financial health of NMAX is average, but there are quite some concerns on its profitability. NMAX is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year NMAX has reported negative net income.
NMAX Yearly Net Income VS EBIT VS OCF VS FCFNMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

  • NMAX has a Return On Assets of -77.73%. This is amonst the worse of the industry: NMAX underperforms 82.42% of its industry peers.
  • NMAX has a worse Return On Equity (-171.17%) than 72.53% of its industry peers.
Industry RankSector Rank
ROA -77.73%
ROE -171.17%
ROIC N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NMAX Yearly ROA, ROE, ROICNMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 0 200 -200 400 600 800

1.3 Margins

  • With a Gross Margin value of 45.23%, NMAX perfoms like the industry average, outperforming 53.85% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for NMAX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NMAX Yearly Profit, Operating, Gross MarginsNMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 20 -20 40 -40

5

2. Health

2.1 Basic Checks

  • NMAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, NMAX has about the same amount of shares outstanding.
  • The debt/assets ratio for NMAX has been reduced compared to a year ago.
NMAX Yearly Shares OutstandingNMAX Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 20M 40M 60M 80M 100M
NMAX Yearly Total Debt VS Total AssetsNMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 50M 100M

2.2 Solvency

  • Based on the Altman-Z score of 1.05, we must say that NMAX is in the distress zone and has some risk of bankruptcy.
  • NMAX has a Altman-Z score (1.05) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.00 indicates that NMAX is not too dependend on debt financing.
  • The Debt to Equity ratio of NMAX (0.00) is better than 87.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACCN/A
WACC8.72%
NMAX Yearly LT Debt VS Equity VS FCFNMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 -20M -40M

2.3 Liquidity

  • A Current Ratio of 2.74 indicates that NMAX has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.74, NMAX belongs to the top of the industry, outperforming 87.91% of the companies in the same industry.
  • NMAX has a Quick Ratio of 2.71. This indicates that NMAX is financially healthy and has no problem in meeting its short term obligations.
  • NMAX's Quick ratio of 2.71 is amongst the best of the industry. NMAX outperforms 90.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.74
Quick Ratio 2.71
NMAX Yearly Current Assets VS Current LiabilitesNMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

  • The earnings per share for NMAX have decreased strongly by -68.55% in the last year.
  • Looking at the last year, NMAX shows a very strong growth in Revenue. The Revenue has grown by 26.42%.
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 21.73% on average over the next years. This is a very strong growth
  • NMAX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.51% yearly.
EPS Next Y-62.25%
EPS Next 2Y37.92%
EPS Next 3Y27.18%
EPS Next 5Y21.73%
Revenue Next Year7.95%
Revenue Next 2Y10.85%
Revenue Next 3Y11.35%
Revenue Next 5Y13.51%

3.3 Evolution

NMAX Yearly Revenue VS EstimatesNMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M 250M
NMAX Yearly EPS VS EstimatesNMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 2028 0 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

  • NMAX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NMAX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NMAX Price Earnings VS Forward Price EarningsNMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60 -80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NMAX Per share dataNMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

  • NMAX's earnings are expected to grow with 27.18% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.92%
EPS Next 3Y27.18%

0

5. Dividend

5.1 Amount

  • No dividends for NMAX!.
Industry RankSector Rank
Dividend Yield 0%

NEWSMAX INC

NYSE:NMAX (2/23/2026, 8:04:49 PM)

Premarket: 5.61 +0.05 (+0.9%)

5.56

-0.06 (-1.07%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-13
Earnings (Next)03-30
Inst Owners30%
Inst Owner Change650.14%
Ins OwnersN/A
Ins Owner Change0%
Market Cap717.96M
Revenue(TTM)308.03M
Net Income(TTM)-181.37M
Analysts82.5
Price Target20.91 (276.08%)
Short Float %6.21%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1367.09%
Min EPS beat(2)-2792.16%
Max EPS beat(2)57.98%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.16%
Min Revenue beat(2)0.92%
Max Revenue beat(2)1.4%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.65%
EPS NQ rev (1m)50%
EPS NQ rev (3m)50%
EPS NY rev (1m)0%
EPS NY rev (3m)-37.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.4%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.33
P/FCF N/A
P/OCF N/A
P/B 6.78
P/tB 6.78
EV/EBITDA N/A
EPS(TTM)-1.41
EYN/A
EPS(NY)-0.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.39
BVpS0.82
TBVpS0.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -77.73%
ROE -171.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.23%
FCFM N/A
ROA(3y)-53.26%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.74
Quick Ratio 2.71
Altman-Z 1.05
F-ScoreN/A
WACC8.72%
ROIC/WACCN/A
Cap/Depr(3y)90.3%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.87%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-68.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-62.25%
EPS Next 2Y37.92%
EPS Next 3Y27.18%
EPS Next 5Y21.73%
Revenue 1Y (TTM)26.42%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year7.95%
Revenue Next 2Y10.85%
Revenue Next 3Y11.35%
Revenue Next 5Y13.51%
EBIT growth 1Y-229.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year77.61%
EBIT Next 3Y28.87%
EBIT Next 5Y25.53%
FCF growth 1Y-946.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1170.71%
OCF growth 3YN/A
OCF growth 5YN/A

NEWSMAX INC / NMAX FAQ

Can you provide the ChartMill fundamental rating for NEWSMAX INC?

ChartMill assigns a fundamental rating of 2 / 10 to NMAX.


What is the valuation status of NEWSMAX INC (NMAX) stock?

ChartMill assigns a valuation rating of 1 / 10 to NEWSMAX INC (NMAX). This can be considered as Overvalued.


What is the profitability of NMAX stock?

NEWSMAX INC (NMAX) has a profitability rating of 0 / 10.


What is the financial health of NEWSMAX INC (NMAX) stock?

The financial health rating of NEWSMAX INC (NMAX) is 5 / 10.


Can you provide the expected EPS growth for NMAX stock?

The Earnings per Share (EPS) of NEWSMAX INC (NMAX) is expected to decline by -62.25% in the next year.